drugset / Trial / NCT01108393
Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
The study will evaluate the efficacy of agomelatine compared to placebo on the reduction of Obsessive and Compulsive symptoms after 16 weeks of treatment.
Timeline
- Start
- 2010-05
- Primary completion
- 2012-08
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Agomelatine | Small molecule | 25 mg | Oral |
| Subject | Agomelatine | Small molecule | 50 mg | Oral |